On the public citation graph

Subcellular orchestration of alpha-synuclein variants in Parkinson’s disease brains revealed by 3D multicolor STED microscopy

0 signed · 87 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archneur.1969.00480180071006openalex-snapshot
Sphingomyelin in Lewy Inclusion Bodies in Parkinson's Disease
inferredcites →https://doi.org/10.1002/mds.26562openalex-snapshot
Lysosomal Dysfunction and α‐Synuclein Aggregation in Parkinson's Disease: Diagnostic Links
inferredcites →https://doi.org/10.1002/mus.26140openalex-snapshot
Label‐free identification of myopathological features with coherent anti‐Stokes Raman scattering
inferredcites →https://doi.org/10.1006/exnr.2000.7527openalex-snapshot
In Situ and in Vitro Study of Colocalization and Segregation of α-Synuclein, Ubiquitin, and Lipids in Lewy Bodies
inferredcites →https://doi.org/10.1006/jmbi.2001.4538openalex-snapshot
Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. Wright
inferredcites →https://doi.org/10.1007/978-1-61779-931-0_11openalex-snapshot
Kinetic Screening in the Antibody Development Process
inferredcites →https://doi.org/10.1007/s00401-012-0964-xopenalex-snapshot
An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology
inferredcites →https://doi.org/10.1007/s00702-014-1353-5openalex-snapshot
BrainNet Europe’s Code of Conduct for brain banking
inferredcites →https://doi.org/10.1007/s12035-012-8280-yopenalex-snapshot
The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders
inferredcites →https://doi.org/10.1016/0896-6273(95)90040-3openalex-snapshot
Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
inferredcites →https://doi.org/10.1016/0896-6273(95)90302-xopenalex-snapshot
The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
inferredcites →https://doi.org/10.1016/j.ajpath.2012.11.018openalex-snapshot
Axonopathy in an α-Synuclein Transgenic Model of Lewy Body Disease Is Associated with Extensive Accumulation of C-Terminal–Truncated α-Synuclein
inferredcites →https://doi.org/10.1016/j.arr.2014.07.002openalex-snapshot
Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases
inferredcites →https://doi.org/10.1016/j.bpj.2014.03.025openalex-snapshot
Automated Identification of Subcellular Organelles by Coherent Anti-Stokes Raman Scattering
inferredcites →https://doi.org/10.1016/j.jmb.2013.03.031openalex-snapshot
The Mysterious C-Terminal Tail of Alpha-Synuclein: Nanobody's Guess
inferredcites →https://doi.org/10.1016/j.nbd.2015.12.018openalex-snapshot
Dynamic structural flexibility of α-synuclein
inferredcites →https://doi.org/10.1016/j.nbd.2018.02.019openalex-snapshot
Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy
inferredcites →https://doi.org/10.1016/j.neuron.2011.08.033openalex-snapshot
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
inferredcites →https://doi.org/10.1016/j.neuroscience.2011.10.042openalex-snapshot
α-synuclein phosphorylation and truncation are normal events in the adult human brain
inferredcites →https://doi.org/10.1016/j.plipres.2015.10.005openalex-snapshot
Interaction of α-synuclein with biomembranes in Parkinson's disease —role of cardiolipin
inferredcites →https://doi.org/10.1016/s0022-510x(03)00144-8openalex-snapshot
A paced visual serial addition test for fMRI
inferredcites →https://doi.org/10.1016/s0079-6123(10)83007-9openalex-snapshot
Role of post-translational modifications in modulating the structure, function and toxicity of α-synuclein
inferredcites →https://doi.org/10.1016/s0091-679x(08)60963-2openalex-snapshot
Chapter 16 The Use of Fluorescent DNA-Binding Agent for Detecting and Separating Yeast Mitochondrial DNA
inferredcites →https://doi.org/10.1016/s0197-4580(02)00065-9openalex-snapshot
Staging of brain pathology related to sporadic Parkinson’s disease
inferredcites →https://doi.org/10.1016/s0962-8924(00)01852-3openalex-snapshot
Aggresomes, inclusion bodies and protein aggregation
inferredcites →https://doi.org/10.1016/s1474-4422(04)00827-0openalex-snapshot
Lewy-body formation is an aggresome-related process: a hypothesis
inferredcites →https://doi.org/10.1016/s1474-4422(15)00006-xopenalex-snapshot
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
inferredcites →https://doi.org/10.1021/bi027363ropenalex-snapshot
Role of α-Synuclein Carboxy-Terminus on Fibril Formation in Vitro
inferredcites →https://doi.org/10.1021/bi048453uopenalex-snapshot
Impact of the Acidic C-Terminal Region Comprising Amino Acids 109−140 on α-Synuclein Aggregation in Vitro
inferredcites →https://doi.org/10.1038/ncb748openalex-snapshot
α-Synuclein is phosphorylated in synucleinopathy lesions
inferredcites →https://doi.org/10.1038/ncomms11359openalex-snapshot
Phosphorylation modifies the molecular stability of β-amyloid deposits
inferredcites →https://doi.org/10.1038/nrn3406openalex-snapshot
The many faces of α-synuclein: from structure and toxicity to therapeutic target
inferredcites →https://doi.org/10.1038/s41593-019-0423-2openalex-snapshot
Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes
inferredcites →https://doi.org/10.1038/srep05797openalex-snapshot
Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry
inferredcites →https://doi.org/10.1039/c6an02072kopenalex-snapshot
Virtual staining of colon cancer tissue by label-free Raman micro-spectroscopy
inferredcites →https://doi.org/10.1073/pnas.0406976102openalex-snapshot
Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
inferredcites →https://doi.org/10.1073/pnas.1309991110openalex-snapshot
Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo
inferredcites →https://doi.org/10.1073/pnas.1610099113openalex-snapshot
Caspase-1 causes truncation and aggregation of the Parkinson’s disease-associated protein α-synuclein
inferredcites →https://doi.org/10.1073/pnas.95.11.6469openalex-snapshot
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
inferredcites →https://doi.org/10.1074/jbc.m116.759373openalex-snapshot
Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated α-Synuclein-selective Autophagic Degradation
inferredcites →https://doi.org/10.1074/jbc.m208046200openalex-snapshot
Phosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy Lesions
inferredcites →https://doi.org/10.1074/jbc.m501508200openalex-snapshot
A Precipitating Role for Truncated α-Synuclein and the Proteasome in α-Synuclein Aggregation
inferredcites →https://doi.org/10.1074/jbc.m600933200openalex-snapshot
Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease
inferredcites →https://doi.org/10.1074/jbc.m800747200openalex-snapshot
Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-Synuclein
inferredcites →https://doi.org/10.1074/mcp.r113.032730openalex-snapshot
Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
inferredcites →https://doi.org/10.1093/hmg/ddu112openalex-snapshot
Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice
inferredcites →https://doi.org/10.1093/jnen/62.12.1241openalex-snapshot
Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62
inferredcites →https://doi.org/10.1097/00005072-196507000-00003openalex-snapshot
PHASE AND ELECTRON MICROSCOPIC OBSERVATIONS OF LEWY BODIES AND MELANIN GRANULES IN THE SUBSTANTIA NIGRA AND LOCUS CAERULEUS IN PARKINSONʼS DISEASE
inferredcites →https://doi.org/10.1097/00005072-199603000-00001openalex-snapshot
Neuropathology of Parkinsonʼs Disease
inferredcites →https://doi.org/10.1097/nen.0b013e3181633526openalex-snapshot
Assessment of α-Synuclein Pathology: A Study of the BrainNet Europe Consortium
inferredcites →https://doi.org/10.1101/500058openalex-snapshot
The making of a Lewy body: the role of alpha-synuclein post-fibrillization modifications in regulating the formation and the maturation of pathological inclusions.
inferredcites →https://doi.org/10.1101/cshperspect.a024091openalex-snapshot
Cell Biology and Pathophysiology of α-Synuclein
inferredcites →https://doi.org/10.1111/bpa.12344openalex-snapshot
L ewy Bodies and the Mechanisms of Neuronal Cell Death in P arkinson's Disease and Dementia with L ewy Bodies
inferredcites →https://doi.org/10.1111/j.1750-3639.2008.00140.xopenalex-snapshot
Three‐Layered Structure Shared Between Lewy Bodies and Lewy Neurites—Three‐Dimensional Reconstruction of Triple‐Labeled Sections
inferredcites →https://doi.org/10.1111/j.1750-3639.2011.00509.xopenalex-snapshot
Pale Neurites, Premature α‐Synuclein Aggregates with Centripetal Extension from Axon Collaterals
inferredcites →https://doi.org/10.1111/j.1750-3639.2012.00585.xopenalex-snapshot
Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type Synucleinopathies
inferredcites →https://doi.org/10.1111/j.1750-3639.2012.00597.xopenalex-snapshot
Critical Role of Truncated α‐Synuclein and Aggregates in Parkinson's Disease and Incidental Lewy Body Disease
inferredcites →https://doi.org/10.1523/jneurosci.08-08-02804.1988openalex-snapshot
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
inferredcites →https://doi.org/10.1523/jneurosci.5314-13.2014openalex-snapshot
Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
inferredcites →https://doi.org/10.2353/ajpath.2007.061232openalex-snapshot
Calpain-Cleavage of α-Synuclein
inferredcites →https://doi.org/10.3233/jpd-160779openalex-snapshot
Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/mds.27897openalex-snapshot
CSF or Serum Neurofilament Light Added to α‐Synuclein Panel Discriminates Parkinson's From Controls
inferred← citeshttps://doi.org/10.1007/s00401-021-02313-3openalex-snapshot
LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson’s disease and dementia with Lewy bodies
inferred← citeshttps://doi.org/10.1016/j.nbd.2020.104876openalex-snapshot
Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports
inferred← citeshttps://doi.org/10.1038/s41531-022-00357-0openalex-snapshot
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
inferred← citeshttps://doi.org/10.1038/s41531-023-00604-yopenalex-snapshot
Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases
inferred← citeshttps://doi.org/10.1038/s41531-025-01084-yopenalex-snapshot
Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation
inferred← citeshttps://doi.org/10.1038/s41583-020-00416-6openalex-snapshot
Reverse engineering Lewy bodies: how far have we come and how far can we go?
inferred← citeshttps://doi.org/10.1073/pnas.1913904117openalex-snapshot
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
inferred← citeshttps://doi.org/10.1073/pnas.2011196118openalex-snapshot
Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease
inferred← citeshttps://doi.org/10.1073/pnas.2114405119openalex-snapshot
In situ proximity labeling identifies Lewy pathology molecular interactions in the human brain
inferred← citeshttps://doi.org/10.1088/1478-3975/ab694eopenalex-snapshot
Advanced fluorescence imaging of in situ protein aggregation
inferred← citeshttps://doi.org/10.1101/2021.04.25.441304openalex-snapshot
Super-resolution microscopy informs on the molecular architecture of alpha-synuclein inclusions in model systems and in the human brain
inferred← citeshttps://doi.org/10.1101/2022.06.08.495286openalex-snapshot
Human pericytes degrade α-synuclein aggregates in a strain-dependent manner
inferred← citeshttps://doi.org/10.1101/2023.07.16.549189openalex-snapshot
Altered TFEB subcellular localization in nigral dopaminergic neurons of subjects with prodromal, sporadic and GBA -related Parkinson’s disease and Dementia with Lewy bodies
inferred← citeshttps://doi.org/10.1101/2024.11.29.625993openalex-snapshot
Dissecting the differential role of C-terminal truncations in the regulation of aSyn pathology formation and the biogenesis of Lewy bodies
inferred← citeshttps://doi.org/10.1101/654582openalex-snapshot
Two new polymorphic structures of alpha-synuclein solved by cryo-electron microscopy
inferred← citeshttps://doi.org/10.1111/jnc.14965openalex-snapshot
Synucleinopathies: Where we are and where we need to go
inferred← citeshttps://doi.org/10.1146/annurev-neuro-100720-034518openalex-snapshot
Parkinson's Disease Genetics and Pathophysiology
inferred← citeshttps://doi.org/10.1155/2023/8848642openalex-snapshot
Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1186/s40478-020-01091-5openalex-snapshot
Label-free vibrational imaging of different Aβ plaque types in Alzheimer’s disease reveals sequential events in plaque development
inferred← citeshttps://doi.org/10.3389/fnagi.2021.690293openalex-snapshot
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
inferred← citeshttps://doi.org/10.3389/fnins.2021.689938openalex-snapshot
Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies
inferred← citeshttps://doi.org/10.3389/fnins.2021.690013openalex-snapshot
Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders
inferred← citeshttps://doi.org/10.3410/f.737400163.793571512openalex-snapshot
Faculty Opinions recommendation of The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.
inferred← citeshttps://doi.org/10.4103/1673-5374.264453openalex-snapshot
Study of alpha-synuclein fibrillation: state of the art and expectations
inferred← citeshttps://doi.org/10.7554/elife.48907openalex-snapshot
Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.